Compliance SweepBack to stories →
← Back to stories

SB 1047 extends neurodegenerative registry authority

SB 1047 adds frontotemporal degeneration to California's neurodegenerative registry framework and extends the chapter to January 1, 2032. Reporting still depends on designated conditions, advance department notice and prescribed formats, and the program remains limited by available funding.

Illustrative artwork. Fictional scene, not a photograph of the people or events in this story.

What happened

California enacted SB 1047 on September 30 as Chapter 1000. Amended Health and Safety Code section 103871 expressly includes frontotemporal degeneration alongside ALS in the incidence-and-prevalence collection system, and adds other dementias to the nonexclusive disease examples. The department must designate reportable diseases and provide the specified website, association, and Medical Board notice at least 90 days before requiring information. The chapter now sunsets January 1, 2032 rather than its prior 2028 endpoint. Those enactment and sunset facts do not establish a newly activated reporting date for every listed condition.

The retained framework requires diagnosing or treating providers and facilities to report each covered case in the department-prescribed format. It permits departmental access and cost recovery if a facility does not report properly, and provides civil penalties for willfully refusing relevant record access. Information collected is confidential except as the chapter otherwise permits. Implementation is expressly limited to available funds. Actual disease designations, notice dates, formats, and funding implementation therefore remain necessary to determine a particular provider's reporting responsibilities; the law alone does not prove that every potential dementia category is newly reportable immediately.

Scope and timing

Authority status
Final
Applicability
Potentially applicable
Audience
Health systems, Provider networks, Health-tech
Jurisdiction
California
Recorded date
2027-01-01
Date type
effective

Why it matters

Neurology data teams should monitor the actual reportable-condition scope.

Sources

Complete edition and supplemental material

This finding in the complete approved report →

Regulatory horizons, CIA trends and implementation trackers remain in the full report.

Read the entire Compliance Sweep report →

← Return to stories

Privacy preferences

Where enabled for this site, Cloudflare Web Analytics can send page-use and performance measurements to Cloudflare. This panel provides information and does not turn analytics on or off.

This panel stores no tracking choice and does not change your tool saves, screening, resets, reports or exports. Other sites have separate settings.

Read Privacy & Cookies